CrossrefInfokarte
Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma
Journal of Clinical and Experimental Hematopathology · 2023-12-26 · 63 (4) · 262-265
DOI: 10.3960/jslrt.23043 ↗Abstract
Kein Abstract verfügbar.
EUVIMED